Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Suskind

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Inflammatory Bowel Diseases|February 4, 2015
Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's diseaseDavid L Suskind, Mitchell J Brittnacher, Ghassan Wahbeh, et al.
Nutrients|December 9, 2020
The Specific Carbohydrate Diet and Diet Modification as Induction Therapy for Pediatric Crohn's Disease: A Randomized Diet Controlled TrialDavid L Suskind, Dale Lee, Young-Mo Kim, et al.
Healthcare (Basel, Switzerland)|November 6, 2019
Evaluating the Comparative Effectiveness of Two Diets in Pediatric Inflammatory Bowel Disease: A Study Protocol for a Series of N-of-1 TrialsHeather C Kaplan, Lisa Opipari-Arrigan, Christopher H Schmid, et al.
Inflammatory Bowel Diseases|July 8, 2026
Metabolome remodeling with reverse-engineered exclusive enteral nutrition in children with active Crohn's diseaseDavid L Suskind, Lucas R Hoffman, Dale Lee, et al.
Journal of Clinical Gastroenterology|December 29, 2016
Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel DiseaseDavid L Suskind, Stanley A Cohen, Mitchell J Brittnacher, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2024
Characterization of Biologic Discontinuation Among Pediatric Patients With Crohn's DiseaseSabina Ali, Brad Pasternak, Jonathan Moses, et al.
JPGN Reports|November 17, 2025
Multicenter study of continuing ustekinumab after intravenous induction reactions in pediatric Crohn's diseaseJoann Samalik, Andrew Singer, Sabina Ali, et al.
Scientific Reports|May 23, 2024
Characterizing the human intestinal chondroitin sulfate glycosaminoglycan sulfation signature in inflammatory bowel diseaseKendra L Francis, Hengqi B Zheng, David L Suskind, et al.
Inflammatory Bowel Diseases|June 3, 2024
Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter ExperienceOren Ledder, Michael Dolinger, Marla C Dubinsky, et al.
The American Journal of Gastroenterology|June 4, 2014
Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patientsColleen R Kelly, Chioma Ihunnah, Monika Fischer, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Inflammatory Bowel Diseases|February 4, 2015
Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's diseaseDavid L Suskind, Mitchell J Brittnacher, Ghassan Wahbeh, et al.
Nutrients|December 9, 2020
The Specific Carbohydrate Diet and Diet Modification as Induction Therapy for Pediatric Crohn's Disease: A Randomized Diet Controlled TrialDavid L Suskind, Dale Lee, Young-Mo Kim, et al.
Healthcare (Basel, Switzerland)|November 6, 2019
Evaluating the Comparative Effectiveness of Two Diets in Pediatric Inflammatory Bowel Disease: A Study Protocol for a Series of N-of-1 TrialsHeather C Kaplan, Lisa Opipari-Arrigan, Christopher H Schmid, et al.
Inflammatory Bowel Diseases|July 8, 2026
Metabolome remodeling with reverse-engineered exclusive enteral nutrition in children with active Crohn's diseaseDavid L Suskind, Lucas R Hoffman, Dale Lee, et al.
Journal of Clinical Gastroenterology|December 29, 2016
Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel DiseaseDavid L Suskind, Stanley A Cohen, Mitchell J Brittnacher, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2024
Characterization of Biologic Discontinuation Among Pediatric Patients With Crohn's DiseaseSabina Ali, Brad Pasternak, Jonathan Moses, et al.
JPGN Reports|November 17, 2025
Multicenter study of continuing ustekinumab after intravenous induction reactions in pediatric Crohn's diseaseJoann Samalik, Andrew Singer, Sabina Ali, et al.
Scientific Reports|May 23, 2024
Characterizing the human intestinal chondroitin sulfate glycosaminoglycan sulfation signature in inflammatory bowel diseaseKendra L Francis, Hengqi B Zheng, David L Suskind, et al.
Inflammatory Bowel Diseases|June 3, 2024
Tofacitinib in Pediatric Ulcerative Colitis: A Retrospective Multicenter ExperienceOren Ledder, Michael Dolinger, Marla C Dubinsky, et al.
The American Journal of Gastroenterology|June 4, 2014
Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patientsColleen R Kelly, Chioma Ihunnah, Monika Fischer, et al.
Pageof 7